It was demonstrated that CD31+ EVs were increased in COPD patients compared to control subjects; higher levels of CD31+ EVs were also associated with the percentage of emphysema on CT scan, reduced PMBF, and lower DLCO. This evidence concerns the gene PECAM1 and pulmonary emphysema.